Get startedLog in
    Picture of Vor Biopharma logo

    VOR — Vor Biopharma News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareSpeculativeMid CapMomentum Trap
    All News

    Vor Biopharma Inc reports results for the quarter ended March 31 - Earnings Summary

    Picture of Vor Biopharma logoVor Biopharma
    15/05/2025 10:09
    Vor Biopharma Inc VOR.OQ reported a quarterly adjusted loss of 26 cents​​ per share for the quarter ended March 31, higher than the same quarter last year, when the company reported EPS of -45 cents.  The mean expectation of seven analysts for the quarter was for a loss of 23 cents per share. Wall Street expected results to range from -33 cents to -13 cents per share.

Reported revenue was zero​; analysts expected zero.

Vor Biopharma Inc's reported EPS for the quarter was a loss of 26 cents​.

The company reported a quarterly loss of $32.49 million.

Vor Biopharma Inc shares had fallen by 76.2% this quarter and lost 84.6% so far this year.

FORECAST CHANGES

The mean earnings estimate of analysts had risen by about 14.1% in the last three months.​

In the last 30 days, one analyst negatively revised an earnings estimate

RECOMMENDATIONS

The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 1 "strong buy" or "buy," 6 "hold" and no "sell" or "strong sell."

Wall Street's median 12-month price target for Vor Biopharma Inc is $0.35

This summary was machine generated from LSEG data May 15 at 09:09 a.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)


    QUARTER ENDINGESTIMATEACTUALBEAT, MET, MISSED
    Mar. 31 2025-0.23-0.26Missed
    Dec. 31 2024-0.29-0.44Missed
    Sep. 30 2024-0.40-0.40Met
    Jun. 30 2024-0.42-0.41Beat

    Recent news on Vor Biopharma

    See all news